Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. - Wikidata - awgldk - TriplyDB

Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice.

Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice.

http://www.wikidata.org/entity/Q34961540

about

BRCA1 is an essential regulator of heart function and survival following myocardial infarction Akt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevity Endogenous S-nitrosothiols protect against myocardial injury Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System Nitric oxide synthases, S-nitrosylation and cardiovascular health: from molecular mechanisms to therapeutic opportunities (review)Nitric oxide synthases in heart failure Using exercise to measure and modify cardiac function Statins in heart failure: do we need another trial?A New Method to Stabilize C-Kit Expression in Reparative Cardiac Mesenchymal Cells.Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases KMUP-3 attenuates ventricular remodelling after myocardial infarction through eNOS enhancement and restoration of MMP-9/TIMP-1 balance.Right Ventricular Adaptation Is Associated with the Glu298Asp Variant of the NOS3 Gene in Elite Athletes.Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver The dynamic regulation of microcirculatory conduit function: features relevant to transfusion medicine.O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart.Natural aminoacyl tRNA synthetase fragment enhances cardiac function after myocardial infarction.MicroRNA-539 is up-regulated in failing heart, and suppresses O-GlcNAcase expression.Female resistance to pneumonia identifies lung macrophage nitric oxide synthase-3 as a therapeutic target Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction High fat feeding in mice is insufficient to induce cardiac dysfunction and does not exacerbate heart failure.Reactive oxygen species in cardiovascular disease.Exercise protects against chronic β-adrenergic remodeling of the heart by activation of endothelial nitric oxide synthase.Lysophosphatidylcholine up-regulates human endothelial nitric oxide synthase gene transactivity by c-Jun N-terminal kinase signalling pathway Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension Induction of activating transcription factor 3 limits survival following infarct-induced heart failure in mice.Nitric oxide promotes distant organ protection: evidence for an endocrine role of nitric oxide.Prognostic markers in heart failure--congestion, neurohormones, and the cardiorenal syndrome.Regulation of DDAH1 as a Potential Therapeutic Target for Treating Cardiovascular Diseases.Nitrite therapy improves left ventricular function during heart failure via restoration of nitric oxide-mediated cytoprotective signaling.Constitutive nitric oxide synthases in the heart from hypertrophy to failure.Nitrite Therapy Ameliorates Myocardial Dysfunction via H2S and Nuclear Factor-Erythroid 2-Related Factor 2 (Nrf2)-Dependent Signaling in Chronic Heart Failure Effect of asymmetric dimethylarginine (ADMA) on heart failure development.Echocardiography in translational research: of mice and men.Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice.Sphingosine-1-phosphate receptor signalling in the heart.Endothelium-driven myocardial growth or nitric oxide at the crossroads.Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury.Ventricular remodeling and function: insights using murine echocardiography.Gene expression and genetic variation in human atria.

P2860

Q24300290-0AE6AF4F-D27A-4307-ACFC-3667AB0AB444 Q24647370-97FC9FC3-EA84-4AB6-9F0B-9BB33572B2DE Q24658413-4BB502F6-4119-4A60-9663-9BC0CDC85E86 Q26774063-765A3A50-9DC8-45C3-A1F8-939DF5280DC1 Q26823520-58158521-06DE-4E15-83AC-5CD20696E880 Q26830146-49E3DADA-7334-4263-BDD9-D06E58062846 Q26994995-4614C7EA-3786-43CB-A8DF-31E36A5EFEB8 Q26998966-6C4E8D6C-6815-47B7-B58B-3500208D29DF Q27330396-4270C179-9C62-40F3-BC07-84260347AFD0 Q28073279-05E29C6E-5564-4FD7-ADAC-11D7F54E0D8F Q30471701-F4FE6402-2F33-4297-AEE2-DB901C75B536 Q31013454-33FCC72C-38CB-49C7-887E-54E75B62F752 Q33743659-87BFD9EF-3773-49B6-A580-2DD65E61C5CA Q34060215-301EFF72-5198-437A-A7DE-8A0CAADDEF18 Q34199818-7246AEE1-996C-45CB-AB8D-1B3DF50AD7D1 Q34308682-C85EF5C3-910E-4DC6-A93F-EB6E7AD57735 Q34396795-326F7978-D8E4-4D96-98A6-7C10AA9A6994 Q34432608-7205849E-788F-4D07-A1A5-1F14D52D814E Q34913082-453E10CD-83FB-445F-8F2A-D06E5E6A7E27 Q35075534-58A5B0C9-82FD-4395-A8A2-849EC10EDCCC Q35165194-61000172-90A3-4D65-8695-F1BDFC17C5E6 Q35165245-102A90A1-EA02-485F-A1D0-8C78FEEB823E Q35832000-CB025FC9-8D9D-49F9-BD3A-30B270F5E681 Q36148204-293FFBB7-2A29-4FC9-83B5-4016FE9FB4CD Q36339385-F9C9D259-30B1-41A3-B7EB-DA83AB09EC7C Q36837493-3E6A6144-E923-42B3-B324-0C6B17459F92 Q36950077-CD9AC5A9-4766-4721-BEF0-7E8BCA00AAEA Q37009925-00B7695A-43CF-4F9E-B4EF-3F1DA9A6D59A Q37090170-34E2B7C2-2F41-4F61-A3CA-9F67B9E56D53 Q37097144-4329D5BC-A936-43C5-851E-56C1BBF0926B Q37240382-101706EA-1F41-4BE1-9207-20F7722FA084 Q37245523-24A3674B-47ED-4246-BD12-8FC227CB5DC4 Q37250743-332F1931-CC81-42A7-A27F-D796BFC6C37C Q37259538-2A7525A8-107B-4361-8407-12E77DB9997A Q37368081-2D700682-C6B9-40B8-A964-58AA3DC0B68D Q37413862-017E3D46-A199-4FBE-A422-5733FE85935F Q37432852-2DC64189-AA9E-46DC-BE13-8B166076CE58 Q37484960-2B18ADDD-CF68-435B-B709-D49F30ED0CA3 Q37554908-DFA018F2-F7AD-4494-8AEE-8D7839A0885F Q37625175-34AFB118-06F9-4997-AA40-7322616D6492

P2860

Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice.

http://www.wikidata.org/entity/Q34961540

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Endothelial nitric oxide synth ...... gestive heart failure in mice.

@ast

Endothelial nitric oxide synth ...... gestive heart failure in mice.

@en

Endothelial nitric oxide synth ...... gestive heart failure in mice.

@nl

type

label

Endothelial nitric oxide synth ...... gestive heart failure in mice.

@ast

Endothelial nitric oxide synth ...... gestive heart failure in mice.

@en

Endothelial nitric oxide synth ...... gestive heart failure in mice.

@nl

prefLabel

Endothelial nitric oxide synth ...... gestive heart failure in mice.

@ast

Endothelial nitric oxide synth ...... gestive heart failure in mice.

@en

Endothelial nitric oxide synth ...... gestive heart failure in mice.

@nl

P1433

Q34961540-64E08A75-F8D9-4EB0-ACB9-D5C28C7C3DFC

P1476

Q34961540-18EFCA51-CD07-4426-BF3D-68E0CD9B42BF

P2093

Q34961540-05E8F18C-261F-45D1-B04B-3C4F64B3FF5A

Q34961540-06023DF5-590E-453E-B4B9-E2EE52BFC375

Q34961540-431B5314-63C9-46FB-8316-A5CE58325327

Q34961540-A334DD97-A114-4F1D-954E-24399DD92E08

Q34961540-DFC8A3AF-CCC8-42F1-8B8F-0436CD048AD5

Q34961540-F2E7FEC2-3305-40CA-BD19-248A1736E187

P2860

Q34961540-0D515999-8438-48CB-92C8-DEAC328B708A

Q34961540-0EF79510-D2C5-47D1-9FCF-8DFAC91E5B7F

Q34961540-187E5E57-B3CD-47C1-B87C-9394D04BF861

Q34961540-20C097E8-7057-4F4C-AC23-372F77E2FAC2

Q34961540-235EF308-6FCA-418D-9798-DBBFE137688D

Q34961540-3BE20967-3B71-4640-ABEB-57E64A06A169

Q34961540-496FF356-94BF-431F-86EE-CA332BB2C1D5

Q34961540-4D08536F-1CCD-4BEF-8D17-E710C2C685E7

Q34961540-4F65AD61-477A-4AE5-8638-0365B6198164

Q34961540-58CE696E-FFC0-4731-994E-F00DDE9D1FF3

P304

Q34961540-8F4FD462-892C-4DAA-B19E-55F413B4A940

P31

Q34961540-3B5EA366-4EB6-4769-8679-6C66701D936D

P356

Q34961540-842311D9-1895-48A5-9052-C548A998E923

P407

Q34961540-244E4147-1A18-4ACF-BF24-C66CF3A396A5

P433

Q34961540-709D873C-2EAF-473E-BBA2-55D84919042C

P478

Q34961540-08B5BD9D-52B9-43B0-B842-480FEA00C5D4

P577

Q34961540-0B18DDD0-4C98-4E7E-A5F1-FED7DCC2FCAC

P5875

Q34961540-212C998D-D166-45F7-9C82-176A50BF8371

P698

Q34961540-8DABB32C-737D-4EF9-89CD-72FEC3D3B418

P921

Q34961540-4A5123BB-52B4-4FB3-9F2B-A1E578780186

Q34961540-5D2A5B5A-15D6-4F4C-B444-2F79309F3FA1

Q34961540-AA2F850F-5BCA-44F0-8E6F-758891C29B75

P932

Q34961540-4E429A12-3EB8-4801-B3D6-9C38C2EF1B41

P356

PNAS.0837428100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Endothelial nitric oxide synth ...... gestive heart failure in mice.

@en

P2093

David J Lefer

http://www.w3.org/2001/XMLSchema#string

Dirk J Duncker

http://www.w3.org/2001/XMLSchema#string

James J M Greer

http://www.w3.org/2001/XMLSchema#string

Rien van Haperen

http://www.w3.org/2001/XMLSchema#string

Rini de Crom

http://www.w3.org/2001/XMLSchema#string

Steven P Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase

Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation

Cellular regulation of endothelial nitric oxide synthase

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

Increased inactivation of nitric oxide is involved in coronary endothelial dysfunction in heart failure.

Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview.

Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3.

Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase.

Nitric oxide: an endogenous modulator of leukocyte adhesion.

Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine.

P304

4891-4896

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0837428100

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10820866

http://www.w3.org/2001/XMLSchema#string

P698

12676984

http://www.w3.org/2001/XMLSchema#string

P921

P932

153651

http://www.w3.org/2001/XMLSchema#string